|
C16ORF61 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.678300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.735500E-02 |
| Normal-vs-Stage2 |
9.338600E-01 |
| Normal-vs-Stage3 |
9.945000E-01 |
| Normal-vs-Stage4 |
6.205400E-01 |
| Stage1-vs-Stage2 |
2.200600E-01 |
| Stage1-vs-Stage3 |
1.571410E-01 |
| Stage1-vs-Stage4 |
1.370970E-01 |
| Stage2-vs-Stage3 |
9.597000E-01 |
| Stage2-vs-Stage4 |
5.590400E-01 |
| Stage3-vs-Stage4 |
6.413800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.846000E-02 |
| Normal-vs-AfricanAmerican |
3.697400E-01 |
| Normal-vs-Asian |
4.234600E-01 |
| Caucasian-vs-AfricanAmerican |
4.473200E-01 |
| Caucasian-vs-Asian |
6.363200E-01 |
| AfricanAmerican-vs-Asian |
4.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.643800E-02 |
| Normal-vs-Female |
7.595400E-01 |
| Male-vs-Female |
1.144400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.462600E-01 |
| Normal-vs-Extreme_Weight |
4.342200E-03 |
| Normal-vs-Obese |
1.524360E-01 |
| Normal-vs-Extreme_Obese |
4.651600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.698700E-03 |
| Normal_Weight-vs-Obese |
7.234400E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.927630E-01 |
| Extreme_Weight-vs-Obese |
3.462600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.255000E-01 |
| Obese-vs-Extreme_Obese |
8.167600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.724400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.177010E-01 |
| Normal-vs-Age(61-80Yrs) |
2.874000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.739030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.768400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.100200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.958600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.411200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.069650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.887500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.373200E-04 |
| Normal-VS-Type2 PRCC |
7.633600E-01 |
| Normal-VS-KIRP CIMP |
1.6697199999971E-05 |
| Normal-VS-Unclassified PRCC |
4.656600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.577500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.82153999999102E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.438000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.924500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.689400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.580700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.241800E-01 |
| Normal-vs-N1 |
1.486170E-01 |
| Normal-vs-N2 |
1.310080E-02 |
| N0-vs-N1 |
3.722000E-02 |
| N0-vs-N2 |
7.695900E-02 |
| N1-vs-N2 |
4.214400E-01 |
|
|
